COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 1079: Articles 10781-10790  | Next

SARS-CoV-2 Omicron Spike Glycoprotein Receptor Binding Domain Exhibits Super-Binder Ability with ACE2 but not Convalescent Monoclonal Antibody
Omotuyi, O. I., Olujide, O., Nash, O., Afolabi, E. O., Oyinloye, B., Fatumo, S., Femi-Oyewo, M., Bogoro, S.
10.1101/2021.12.09.471885 — Posted: 2021-12-09
Modeling COVID-19 Aerosol Transmission in Primary Schools
Swanson, T., Guikema, S. D., Bagian, J., Payne, C.
10.1101/2021.12.08.21267499 — Posted: 2021-12-09
Single cell gene expression profiling of nasal ciliated cells reveals distinctive biological processes related to epigenetic mechanisms in patients with severe COVID-19
Diambra, L., Alonso, A. M., Sookoian, S., Pirola, C.
10.1101/2021.12.08.21267478 — Posted: 2021-12-09
Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay
Sigal, G. B., Novak, T., Mathew, A., Chou, J., Zhang, Y., Manjula, N., Bathala, P., Joe, J., Padmanabhan, N., Romero, D., Allegri-Machado, G., Joerger, J., Loftis, L. L., Schwartz, S. P., Walker, T. C., Fitzgerald, J. C., Tarquinio, K. M., Zinter, M. S., Schuster, J. E., Halasa, N. B., Cullimore, M. L., Maddux, A. B., Staat, M. A., Irby, K., Flori, H. R., Coates, B. M., Crandall, H., Gertz, S. J., Randolph, A. G., Pollock, N. R.
10.1101/2021.12.08.21267502 — Posted: 2021-12-09
Safety and Immunogenicity of SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901 in People Living with HIV
Cheng, S.-H., Lien, C. E., Hsieh, S.-M., Cheng, C.-Y., Liu, W.-D., Lo, C.-L., Ko, W.-c., Chen, Y.-H., Huang, C.-T., Chang, H.-T., Hwang, S.-J., Wang, N.-C., Liu, M.-C., Lee, Y.-L., Tai, I.-C., Estrada, J. A. G., Lin, T.-Y., Lee, W.-S.
10.1101/2021.12.08.21267439 — Posted: 2021-12-09
Vaccinating Children Against COVID-19 is Essential Prior to the Removal of Non-Pharmaceutical Interventions
Rosenstrom, E., Mele, J. A., Ivy, J., Mayorga, M., Patel, M. D., Hassmiller Lich, K., Delamater, P., Smith, R., Swann, J. L.
10.1101/2021.12.08.21267496 — Posted: 2021-12-09
Nanotrap Particles Improve Nanopore Sequencing of SARS-CoV-2 and Other Respiratory Viruses
Andersen, P. D., Barksdale, S., Barclay, R. A., Smith, N., Fernandes, J., Goldfarb, D., Barbero, R., Jones-Roe, T., Besse, K., Dunlap, R., Kelly, R., Miao, S., Ruhunusiri, C., Munns, A., Mosavi, S., Munns, D., Sanson, L., Saswata, S., Swahn, O., Hull, K., White, D., Kolb, K., Noroozi, F., Seelam, J., Patnaik, A., Lepene, B.
10.1101/2021.12.08.471814 — Posted: 2021-12-09
A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection.
Coria, L. M., Saposnik, L. M., Pueblas Castro, C., Castro, E. F., Bruno, L. A., Stone, W. B., Perez, P. S., Darriba, M. L., Chemes, L. B., Alcain, J., Mazzitelli, I., Varese, A., Salvatori, M., Auguste, A. J., Alvarez, D. E., Pasquevich, K. A., Cassataro, J.
10.1101/2021.12.07.471590 — Posted: 2021-12-09
Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
Walls, A. C., Sprouse, K. R., Joshi, A., Bowen, J. E., Franko, N., Navarro, M.-J., Stewart, C., McCallum, M., Goecker, E. A., Degli-Angeli, E. J., Logue, J., Greninger, A., Veesler, D.
10.1101/2021.12.08.471707 — Posted: 2021-12-09
Vaccine hesitancy for COVID-19 explored in a phenomic study of 259 socio-cognitive-behavioural measures in the UK-REACH study of 12,431 UK healthcare workers
McManus, C., Woolf, W., Martin, C. A., Nellums, L. B., Guyatt, A. L., Melbourne, C., Bryant, L., Gupta, A., John, C., Tobin, M. D., Carr, S., Simpson, S., Gregary, B., Aujayeb, A., Zingwe, S., Reza, R., Gray, L. J., Khunti, K., Pareek, M.
10.1101/2021.12.08.21267421 — Posted: 2021-12-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).